Clinical Trial Update: Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes [Phase 3]

View source ↗

Summary

Phase 3 trial exploring empagliflozin combined with linagliptin, metformin, and lifestyle for prediabetes and insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Prediabetes

Drugs mentioned

• Empagliflozin (empagliflozin)
• Linagliptin (linagliptin)
• metformin (metformin)

Snippet

Sponsor: Universidad de Guanajuato | Conditions: Prediabetic State, Insulin Resistance | Phase 3 | Status: UNKNOWN